IGT-303 for renal insufficiency, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Oct 2025: Trial started, NCT07231679
  2. 17 Nov 2025: Trial registered, NCT07231679

The trials

NCT07231679: A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

State
Under way
Phase
Phase 1 and Phase 2
People
94 planned
Started
30 Oct 2025
Primary completion
Dec 2026
Arms
IGT-303
Results
None posted
  1. 30 Oct 2025: Trial started
  2. 17 Nov 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.